BACKGROUND: Asthmatic symptoms in young children reflect a heterogeneous group of diseases. Symptoms remain the primary end-point in both research and clinical management, but there is a need for standardized symptom assessment. OBJECTIVE: We sought to explore endotyping of early childhood asthma by prospective daily diary recordings of globally assessed symptoms during the first 6 years of life. METHODS: Globally assessed troublesome lung symptoms were recorded in daily diaries during the first 6 years of life in the Copenhagen Prospective Studies on Asthma in Childhood birth cohort born of mothers with asthma. Symptom recordings adjusted for missing values were used to categorize children based on the temporal symptom pattern. We propose an alternative approach of quantitating symptom frequency and longitudinal assessment of age-at-onset to segment children. These different methods were compared by estimating the risk from the well-established genetic risk variants of ORMDL3. RESULTS: Six years of daily diary recordings were available in 307 children (75% of the birth cohort). We confirmed the archetypal temporal categories of transient early, persistent, and late-onset troublesome lung symptoms based on 3-year periods, finding no benefit from a finer temporal categorization of 2- or 1-year periods. Restricting categorization to symptoms during the summer improved specificity at the expense of sensitivity. Our alternative approach quantitating symptom frequency and age-at-onset exhibited a more powerful association with ORMDL3, whereas the study power was lost by restricting to doctor-verified wheeze. CONCLUSIONS: We propose a novel method for endotyping of early childhood asthma based on the frequency and age-of-onset of globally assessed troublesome lung symptoms analyzed longitudinally. This method showed the closest association with genetic variants, hence underlying molecular mechanisms and endotypes.
BACKGROUND: Asthmatic symptoms in young children reflect a heterogeneous group of diseases. Symptoms remain the primary end-point in both research and clinical management, but there is a need for standardized symptom assessment. OBJECTIVE: We sought to explore endotyping of early childhood asthma by prospective daily diary recordings of globally assessed symptoms during the first 6 years of life. METHODS: Globally assessed troublesome lung symptoms were recorded in daily diaries during the first 6 years of life in the Copenhagen Prospective Studies on Asthma in Childhood birth cohort born of mothers with asthma. Symptom recordings adjusted for missing values were used to categorize children based on the temporal symptom pattern. We propose an alternative approach of quantitating symptom frequency and longitudinal assessment of age-at-onset to segment children. These different methods were compared by estimating the risk from the well-established genetic risk variants of ORMDL3. RESULTS: Six years of daily diary recordings were available in 307 children (75% of the birth cohort). We confirmed the archetypal temporal categories of transient early, persistent, and late-onset troublesome lung symptoms based on 3-year periods, finding no benefit from a finer temporal categorization of 2- or 1-year periods. Restricting categorization to symptoms during the summer improved specificity at the expense of sensitivity. Our alternative approach quantitating symptom frequency and age-at-onset exhibited a more powerful association with ORMDL3, whereas the study power was lost by restricting to doctor-verified wheeze. CONCLUSIONS: We propose a novel method for endotyping of early childhood asthma based on the frequency and age-of-onset of globally assessed troublesome lung symptoms analyzed longitudinally. This method showed the closest association with genetic variants, hence underlying molecular mechanisms and endotypes.
Authors: Nicklas Brustad; Anders U Eliasen; Jakob Stokholm; Klaus Bønnelykke; Hans Bisgaard; Bo L Chawes Journal: JAMA Date: 2019-03-12 Impact factor: 56.272
Authors: Minal Calışkan; Yury A Bochkov; Eskil Kreiner-Møller; Klaus Bønnelykke; Michelle M Stein; Gaixin Du; Hans Bisgaard; Daniel J Jackson; James E Gern; Robert F Lemanske; Dan L Nicolae; Carole Ober Journal: N Engl J Med Date: 2013-03-27 Impact factor: 91.245
Authors: Bo L Chawes; Klaus Bønnelykke; Pia F Jensen; Ann-Marie M Schoos; Lene Heickendorff; Hans Bisgaard Journal: PLoS One Date: 2014-06-12 Impact factor: 3.240
Authors: Norbert Meyer; Jan W Dallinga; Sarah Janine Nuss; Edwin J C Moonen; Joep J B N van Berkel; Cezmi Akdis; Frederik Jan van Schooten; Günter Menz Journal: Respir Res Date: 2014-11-28
Authors: H Bisgaard; N H Vissing; C G Carson; A L Bischoff; N V Følsgaard; E Kreiner-Møller; B L K Chawes; J Stokholm; L Pedersen; E Bjarnadóttir; A H Thysen; E Nilsson; L J Mortensen; S F Olsen; S Schjørring; K A Krogfelt; L Lauritzen; S Brix; K Bønnelykke Journal: Clin Exp Allergy Date: 2013-12 Impact factor: 5.018
Authors: Johan de Rooi; Sarah K Nørgaard; Morten A Rasmussen; Klaus Bønnelykke; Hans Bisgaard; Age K Smilde Journal: PLoS One Date: 2018-11-29 Impact factor: 3.240
Authors: Klaus Bønnelykke; Patrick Sleiman; Kasper Nielsen; Eskil Kreiner-Møller; Josep M Mercader; Danielle Belgrave; Herman T den Dekker; Anders Husby; Astrid Sevelsted; Grissel Faura-Tellez; Li Juel Mortensen; Lavinia Paternoster; Richard Flaaten; Anne Mølgaard; David E Smart; Philip F Thomsen; Morten A Rasmussen; Silvia Bonàs-Guarch; Claus Holst; Ellen A Nohr; Rachita Yadav; Michael E March; Thomas Blicher; Peter M Lackie; Vincent W V Jaddoe; Angela Simpson; John W Holloway; Liesbeth Duijts; Adnan Custovic; Donna E Davies; David Torrents; Ramneek Gupta; Mads V Hollegaard; David M Hougaard; Hakon Hakonarson; Hans Bisgaard Journal: Nat Genet Date: 2013-11-17 Impact factor: 38.330
Authors: Ni Wang; Ann-Marie M Schoos; Jeppe M Larsen; Susanne Brix; Anna H Thysen; Morten A Rasmussen; Jakob Stokholm; Klaus Bønnelykke; Hans Bisgaard; Bo L Chawes Journal: EBioMedicine Date: 2019-05-02 Impact factor: 8.143
Authors: Bo L Chawes; Giuseppe Giordano; Paola Pirillo; Daniela Rago; Morten A Rasmussen; Jakob Stokholm; Klaus Bønnelykke; Hans Bisgaard; Eugenio Baraldi Journal: Metabolites Date: 2019-09-16
Authors: Klaus Bønnelykke; Nadja Hawwa Vissing; Astrid Sevelsted; Sebastian L Johnston; Hans Bisgaard Journal: J Allergy Clin Immunol Date: 2015-04-21 Impact factor: 10.793